Insmed Inc (INSM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $26.58B
Last updated: Nov 17, 2026 at 11:06 AM ET
Insmed Inc (INSM) Stock Forecast
Analysts expect Insmed (INSM) to earn -$1.67 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.86B. Of 24 analysts, 23 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 5 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 24 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 96% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 5 | 20.8% |
| Buy | 18 | 75.0% |
| Hold | 1 | 4.2% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 24
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 60.8%.
- Fiscal year ending Dec 31, 2026
- -$1.67
- EPS consensus, revenue $1.86B
- Fiscal year ending Dec 31, 2027
- $0.66
- EPS consensus, revenue $2.99B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.67 | -$2.17 to -$0.82 | 17 | $1.86B | $1.84B to $1.89B | 20 |
| Dec 31, 2027 | $0.66 | -$0.82 to $2.02 | 18 | $2.99B | $2.58B to $3.38B | 21 |
Quarterly Estimates
The EPS consensus rises from -$0.33 for the quarter ending Dec 31, 2026 to -$0.28 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.33 | -$1.12 to -$0.02 | 25 | $604.78M | $530.18M to $664.88M | 23 |
| Mar 31, 2027 | -$0.28 | -$0.53 to -$0.06 | 6 | $625.63M | $555.00M to $666.18M | 9 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 9 upward and 13 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 5 |
| Fiscal year ending Dec 31, 2027 | 6 | 8 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.63.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.67 | -$1.59 | -$1.54 | -$1.55 | -$2.63 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.66 | $0.79 | $0.77 | $0.80 | $0.12 | +427.3% |
| Quarter ending Mar 31, 2027 | -$0.28 | -$0.23 | -$0.20 | -$0.20 | -$0.22 | N/A |
Frequently Asked Questions About INSM
What is the INSM stock forecast?
Consensus analyst estimates put Insmed's EPS at -$1.67 for the fiscal year ending Dec 31, 2026, on revenue of $1.86B. The consensus rating from 24 analysts is Buy.
How do analysts rate INSM stock?
Of 24 analysts covering Insmed, 5 rate it Strong Buy, 18 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from INSM next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.67, with estimates from -$2.17 to -$0.82 from 17 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.66, with estimates from -$0.82 to $2.02 from 18 analysts.
What revenue do analysts expect from Insmed next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.86B, with estimates from $1.84B to $1.89B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.99B, with estimates from $2.58B to $3.38B.
How many analysts cover INSM?
24 analysts rate Insmed stock, and 17 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
INSM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts